These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7350856)

  • 21. [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
    Blanloeil Y; Baron D; Gazeau MF; Nicolas F
    Anesth Analg (Paris); 1980; 37(7-8):441-3. PubMed ID: 7425327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
    [No Abstract]   [Full Text] [Related]  

  • 23. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC; Balint G; Dawkins RL
    Scand J Rheumatol Suppl; 1979; (28):91-3. PubMed ID: 287196
    [No Abstract]   [Full Text] [Related]  

  • 24. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease.
    Adelman HM; Winters PR; Mahan CS; Wallach PM
    Am J Med Sci; 1995 Apr; 309(4):191-3. PubMed ID: 7900739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
    Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
    Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
    [No Abstract]   [Full Text] [Related]  

  • 26. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenia gravis pseudoparalytica as a result of penicillamine treatment of rheumatoid arthritis].
    Gietka A
    Reumatologia; 1982; 20(1-2):65-8. PubMed ID: 7163666
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT; Cassady J; Hardin JG
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
    Suzuki H; Imai H; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy.
    Hall CL; Tighe R
    Br J Rheumatol; 1989 Feb; 28(1):53-7. PubMed ID: 2917229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [D-penicillamine-induced myasthenia gravis].
    Murros K; Möttönen T
    Duodecim; 1984; 100(5):292-4. PubMed ID: 6714116
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis and penicillamine therapy of rheumatoid arthritis.
    Bocanegra T; Espinoza LR; Vasey FB; Germain BF
    JAMA; 1980 Oct; 244(16):1822-3. PubMed ID: 7420683
    [No Abstract]   [Full Text] [Related]  

  • 37. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 38. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor.
    Russell AS; Lindstrom JM
    Neurology; 1978 Aug; 28(8):847-9. PubMed ID: 567304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.
    Seideman P; Ayesh R
    Clin Rheumatol; 1994 Sep; 13(3):435-7. PubMed ID: 7835005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE; Humphrey JG; Gordn DA
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.